NEW YORK, June 26, 2013 /PRNewswire/ --
Today, Wall Street Reports announced new research reports highlighting Stryker Corp. (NYSE: SYK), Techne Corp. (NASDAQ: TECH), Hill-Rom Holdings, Inc. (NYSE: HRC), MiMedx Group, Inc. (NASDAQ: MDXG) and Masimo Corporation (NASDAQ: MASI). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Stryker Corp. Research Report
On June 18, 2013, Stryker Corp. (Stryker) announced that it will host a conference call on July 18, 2013, Thursday at 4:30 p.m. ET, to discuss the Company's operating results for the quarter ended June 30, 2013 and to provide an operational update. Stryker informed that a webcast of the call will be accessible via the Company's website simultaneously and the call will be archived on the Company's website for 90 days. The Full Research Report on Stryker Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/5339_SYK]
--
Techne Corp. Research Report
On June 18, 2013, Techne Corp. (Techne) announced that it has agreed to acquire 100% ownership of Bionostics Holdings Limited and its operating subsidiary Bionostics Inc. (Bionostics) for $104 million in cash, subject to adjustment following closing based on the final level of working capital of Bionostics. The acquisition is expected to be slightly accretive to Techne's FY 2014 net earnings. Charles R. Kummeth, President and Chief Executive Officer of Techne, said, "We are delighted to add the Bionostics team to our Hematology division. This business is how Techne R&D Systems was founded some 30 years ago and remains thriving today. The addition of Bionostics adds capabilities in exciting new areas like Coagulation and expands our controls portfolio, giving us the critical mass we need to remain competitive and offer our customers continued value and options to serve their needs." The transaction is expected to close in the Q1 FY2014, subject to the satisfaction of customary closing conditions. The Full Research Report on Techne Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/b17b_TECH]
--
Hill-Rom Holdings, Inc. Research Report
On June 7, 2013, Hill-Rom Holdings Inc. (Hill-Rom) launched the Hill-Rom Hand Hygiene Compliance Solution to help hospitals monitor hand-hygiene rates. As per the Company, the new solution provides real-time monitoring and staff reminders, simplifies reporting, and can use the same hardware and devices as other Hill-Rom real-time locating solutions. "Sometimes the simplest things are the hardest to do, and that is certainly true for hospitals in achieving universal compliance with hand-hygiene guidelines," says Adam McMullin, Vice President and General Manager, Hill-Rom IT Solutions. "The good news for hospitals is that a number of studies have shown that implementing a hand-hygiene monitoring program along with policies and interventions can improve hand-hygiene compliance rates throughout the institution." The Company said that the new Hill-Rom Hand Hygiene Compliance Solution has been implemented in a number of institutions around the country that are participating in a pilot program. The Full Research Report on Hill-Rom Holdings, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/7e71_HRC]
--
MiMedx Group, Inc. Research Report
On June 11, 2013, MiMedx Group, Inc. (MiMedx) announced that it has been issued three new patents related to tissue allografts derived from the placenta. "We are pleased to have been granted three new patents during the second quarter of this year. These three newly issued patents now give us a total of eight dHACM-based U.S. patents that have been issued to MiMedx®," said Parker H. Petit, Chairman and Chief Executive Officer. "We are also pleased that our allografts from our proprietary AmnioFix® and EpiFix® technologies are continuing to gain excellent reception among the physician community and the private and public sector insurance carriers." The Full Research Report on MiMedx Group, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/24c9_MDXG]
--
Masimo Corporation Research Report
On June 19, 2013, Masimo Corp. (Masimo) and South Shore Hospital, jointly announced that South Shore Hospital has converted to Masimo SET pulse oximetry and sensor technologies, used at leading health organizations worldwide. According to the Company, Masimo SET pulse oximetry virtually eliminates false alarms and increases a clinician's ability to detect life-threatening events. It has also shown to help clinicians reduce retinopathy of prematurity, detect critical congenital heart disease in newborns, and save lives in post-surgical floors, recovery, labor and delivery rooms, and ICUs. "We are happy to have forged this great partnership with South Shore Hospital, which like other leading healthcare organizations is demonstrating its commitment to patient safety and care by taking advantage of our breakthrough Measure-Through Motion and Low Perfusion pulse oximetry technology performance," said Masimo Founder and Chief Executive Officer Joe Kiani. "We value this relationship with South Shore, and together look forward to helping their skilled and dedicated staff meet and exceed their patient care needs." The Full Research Report on Masimo Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/6926_MASI]
----
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
SOURCE Wall Street Reports